Outcome and prognostic factors for pituitary carcinomas: lessons from a systematic review
Endocrine-Related Cancer · 27.02.2023 · 30 (5)
DOI: 10.1530/erc-22-0338 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Endocrine-Related Cancer, erschienen am 27.02.2023. Verfasst von Perrine Raymond und 2 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Department, CHRU de Brabois, Vandoeuvre Les Nancy, France. Hauptthemen laut MEDLINE: Pituitary Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 215 Literaturangaben.
Abstract (Originalsprache)
Purpose
The purpose of this work was toinvestigate the clinicopathological characteristics at the initial diagnosis of the pituitary tumor and at pituitary carcinoma (PC) diagnosis, alongside with the management and outcomes of PCs, and identify potential prognostic factors and therapeutic strategies associated with the clinical outcome.
Methods
PubMed was searched in May 2021 for articles in English and French reporting PCs, the diagnosis of which was made on the presence of metastases. The cases without histological proof and with either another cancer present or an atypical history for a pituitary tumor were excluded.
Results
One hundred and eighty-one articles reporting 207 cases were included, which included 38% corticotroph and 29% lactotroph carcinomas. An initial Ki67 index ≥10% was associated with shorter survival after the initial diagnosis ( P = 0.01). Cases with early metastases were associated with both higher initial Ki67 index ( P = 0.01) and shorter survival after PC diagnosis ( P = 0.001). Interestingly, cases with short survival after PC diagnosis were associated with shorter time between the initial diagnosis and PC diagnosis ( P = 0.0006) and had both higher initial Ki67 index ( P = 0.003) and higher Ki67 index of the metastasis ( P = 0.03). In addition, cases with long survival after PC diagnosis had received more frequently both systemic treatment after PC diagnosis ( P = 0.0005) and local treatment for metastases ( P < 0.0001).
Conclusions
An initial Ki67 index ≥10% is associated with worse outcome and appears as a promising early marker of future metastasis. Its presence should lead to an intensified surveillance and to a more timely management. Clinicians should not hesitate to use local treatment, independent of whether systemic treatment is used.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Department, CHRU de Brabois, Vandoeuvre Les Nancy, France.
- Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, "Groupement Hospitalier Est" Hospices Civils de Lyon, Bron, France.
- Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, Lyon, France.
- Endocrinology Department, "C.I. Parhon" National Institute of Endocrinology, Bucharest, Romania.
ORCID-Profile: Gérald Raverot, Mirela-Diana Ilie
Zitieren
APA
Raymond, P., Raverot, G., & Ilie, M. D. (2023). Outcome and prognostic factors for pituitary carcinomas: lessons from a systematic review. Endocrine-Related Cancer, 30(5). https://doi.org/10.1530/erc-22-0338
Vancouver
Raymond P, Raverot G, Ilie MD. Outcome and prognostic factors for pituitary carcinomas: lessons from a systematic review. Endocrine-Related Cancer. 2023;30(5). doi:10.1530/erc-22-0338
BibTeX
@article{Raymond2023,
author = {Raymond, Perrine and Raverot, Gérald and Ilie, Mirela-Diana},
title = {Outcome and prognostic factors for pituitary carcinomas: lessons from a systematic review},
journal = {Endocrine-Related Cancer},
year = {2023},
volume = {30},
number = {5},
doi = {10.1530/erc-22-0338}
}
EUVIMED